RMM Grants Awarded

See where grants have been awarded across Minnesota.
Patrick Walsh, MS
This proposal will expand Anatomic facilities through equipment purchases to establish an independent laboratory. This will create room for…
2021-2022
Artur Serebrenik, PhD
The primary goal of the proposed work is to produce preclinical data to support the use of BIO 300 in patients with triple negative breast cancer…
2021-2022
Ross Dunbar
Our goal is focused on developing the commercial pathway for two translational stem cell related projects in Minnesota, one creating Rapidly…
2021-2022
Maria Athanasiou, PhD
We are developing a one-time treatment for durable remission of HIV in the absence of antiretroviral treatment. This treatment is a regenerative…
2021-2022
Elizabeth Siegler, PhD
Mesenchymal stromal cells (MSCs) have intrinsic immunosuppressive and regenerative properties. We seek to engineer MSCs with artificial receptors to…
2021-2023
Enis Kostallari, PhD
Public Health Relevance: Alcoholic Hepatitis (AH) is a severe liver disease and is a leading cause of morbidity and mortality in the United States of…
2021-2023
Matthew Abdel, MD
Joint stiffening (arthrofibrosis) is a debilitating complication with limited treatment options that is observed in a substantial subset of patients…
2021-2023
Isobel Scarisbrick, PhD
Our goal is to develop a new treatment strategy that improves outcomes in individuals with chronic spinal cord injury. Studies will contribute to the…
2021-2023
Brenda Ogle, PhD
The clinical prognosis for patients with hypertrophic cardiomyopathy (HCM) is very poor and the only long-term alternative is heart transplant. Our…
2021-2023
Walter Low, PhD
The goal of this research is to facilitate the generation of human organs and cells for transplantation and repair of the human body. The generation…
2021-2023
Harald Junge, PhD
Retinal vascular diseases, e.g., diabetic retinopathy, are a leading cause of blindness and place a significant burden on individual patients as well…
2021-2023
Daniel Garry, MD, PhD
Cardiovascular diseases are common and deadly. It is estimated that the U.S. has limited blood supply for those that require transfusions (there are…
2021-2023